Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares · CUSIP: 589492107

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.

    Shares: 32,430,690.00 · Class: 4.1%

  • FHMLSP, L.P.

    Shares: 32,430,690.00 · Class: 4.1%

  • FHMLSP, L.L.C.

    Shares: 32,430,690.00 · Class: 4.1%

  • Frazier Life Sciences Public Overage Fund, L.P.

    Shares: 8,941,155.00 · Class: 1.1%

  • FHMLSP Overage, L.P.

    Shares: 8,941,155.00 · Class: 1.1%

  • FHMLSP Overage, L.L.C.

    Shares: 8,941,155.00 · Class: 1.1%

  • Frazier Life Sciences X, L.P.

    Shares: 1,763,230.00 · Class: 0.2%

  • FHMLS X, L.P.

    Shares: 1,763,230.00 · Class: 0.2%

  • FHMLS X, L.L.C.

    Shares: 1,763,230.00 · Class: 0.2%

  • Frazier Life Sciences XI, L.P.

    Shares: 4,065,485.00 · Class: 0.5%

  • FHMLS XI, L.P.

    Shares: 4,065,485.00 · Class: 0.5%

  • FHMLS XI, L.L.C.

    Shares: 4,065,485.00 · Class: 0.5%

  • James N. Topper

    Shares: 1,763,230.00 · Class: 0.2%

  • Patrick J. Heron

    Shares: 1,763,230.00 · Class: 0.2%

  • Albert Cha

    Shares: 0.00 · Class: 0.0%

  • James Brush

    Shares: 0.00 · Class: 0.0%

  • Daniel Estes

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-021789
Form type
SCHEDULE 13G/A
Filer
Frazier Life Sciences Public Fund, L.P.
CIK
CIK 1863769
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub